Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) EBT Margin (2024 - 2025)

Historic EBT Margin for Prime Medicine (PRME) over the last 2 years, with Q3 2025 value amounting to 4312.82%.

  • Prime Medicine's EBT Margin rose 208154100.0% to 4312.82% in Q3 2025 from the same period last year, while for Sep 2025 it was 3339.28%, marking a year-over-year increase of 240668400.0%. This contributed to the annual value of 6566.61% for FY2024, which is N/A changed from last year.
  • Prime Medicine's EBT Margin amounted to 4312.82% in Q3 2025, which was up 208154100.0% from 4716.68% recorded in Q2 2025.
  • In the past 5 years, Prime Medicine's EBT Margin registered a high of 1936.6% during Q4 2024, and its lowest value of 25128.23% during Q3 2024.